Abstract
Get full access to this article
View all access options for this article.
References
1.
Shirkey
H
. Editorial comment: Therapeutic orphans . J Pediatr.
1968 ;72 :119 –120 .
2.American Academy of Pediatrics, Committee on Drugs.
Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations . Pediatrics.
1995 ;95 :286 –294 .
3.
Kearns
GL
Reed
MD
. Clinical pharmacokinetics in infants and children: a reappraisal . Clin Pharmacokinet.
1989 ;17 (Suppl. 1 ):29 –67 .
4.
Kauffman
RE
Kearns
GL
. Pharmacokinetic studies in pediatric patients: clinical and ethical considerations . Clin Pharmacokinet.
1992 ;23 :10 –29 .
5.
Wilson
JT
Kearns
GL
Murphy
D
Yaffe
SJ
. Pediatric labeling requirements: implications for pharmacokinetic studies . Clin Pharmacokinet.
1994 ;26 :308 –325 .
6.
Farrar
HC
Wells
TG
Kearns
GL
. Paediatric clinical pharmacology: reclaiming the therapeutic orphan . Exp Opin Invest Drugs.
1996 ;5 :7 –13 .
7.
Kearns
GL
. Pharmacogenetics and development: are infants and children at increased risk for adverse outcome? . Curr Opin Pediatr.
1995 ;7 :220 –233 .